Related Experiment Video
Updated: Jul 3, 2026

In Vivo Two-photon Imaging of Megakaryocytes and Proplatelets in the Mouse Skull Bone Marrow
Published on: July 28, 2021
The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation
Chaneun Nam1, Adam J Case, Bruce S Hostager
1Department of Pediatrics, Division of Hematology/Oncology, Carver College of Medicine, University of Iowa, Iowa City, IA, 52242, USA.
Abstract:
Megakaryocytopoiesis is a multistage process that involves differentiation of hematopoietic stem cells through the myeloid lineage, ultimately producing megakaryocytes and platelets. Vasoactive intestinal peptide (VIP) stimulates adenylate cyclase and induces differentiation in multiple cell types; VIP is expressed in hematopoietic stem cells and in megakaryocytes, but its function in these cells has not yet been delineated. The present study was designed to investigate whether the type 1 VIP receptor, VPAC1, mediates VIP effects on megakaryocytopoiesis. The human megakaryoblastic leukemia cell line (CMK) was transfected with VPAC1 and the transgene expression was confirmed by qualitative polymerase chain reaction and immunohistochemistry. The rate of proliferation and the patterns of differentiation were then compared for CMK and CMK/VPAC1 through multiple growth cycles. Upregulation of VPAC1 expression resulted in a decreased proliferation rate (p = 0.0003) and enhanced differentiation with CMK/VPAC1 cells having twice the cell surface area of control CMK cells (p = 0.001), thus increasing potential for proplatelet formation. These results suggest that VIP acts in an autocrine fashion via VPAC1 to inhibit megakaryocyte proliferation and induce proplatelet formation.
Insights
Vasoactive intestinal peptide (VIP) signaling through its VPAC1 receptor inhibits megakaryocyte proliferation and promotes differentiation. This suggests VIP plays a role in megakaryocytopoiesis, the process of producing platelets.
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Megakaryocytopoiesis is crucial for platelet production, involving stem cell differentiation.
- Vasoactive intestinal peptide (VIP) is present in hematopoietic stem cells and megakaryocytes, but its function is unknown.
- The type 1 VIP receptor (VPAC1) is a potential mediator of VIP's effects.
Purpose of the Study:
- To investigate if VPAC1 mediates VIP's effects on megakaryocytopoiesis.
- To determine VIP's role in megakaryocyte proliferation and differentiation.
Main Methods:
- Transfected human megakaryoblastic leukemia (CMK) cells with VPAC1.
- Confirmed transgene expression using PCR and immunohistochemistry.
- Compared proliferation rates and differentiation patterns of CMK and CMK/VPAC1 cells.
Main Results:
- VPAC1 upregulation decreased CMK cell proliferation (p = 0.0003).
- VPAC1 enhanced cell differentiation, doubling cell surface area (p = 0.001).
- Increased cell size suggests enhanced potential for proplatelet formation.
Conclusions:
- VIP acts via VPAC1 in an autocrine manner.
- VIP inhibits megakaryocyte proliferation and induces differentiation.
- VIP signaling through VPAC1 is a key regulator of megakaryocytopoiesis.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
IP3/DAG Signaling Pathway

